In deliveryUnited KingdomGoodsFramework agreement£51,517,832
NP47825 Multiple Sclerosis Medicines
- Published
- Published 7 January 2025
- Deadline
- Closed 7 February 2025
Overview
Supply of multiple sclerosis medicines to NHS Scotland.
Key details
- Country
- United Kingdom
- Status
- In delivery
- Category
- Goods
- Estimated value
- £51,517,832
- Procedure
- Open
- Contract type
- Framework agreement
- Published
- 7 January 2025
- Deadline
- Closed
Pharmaceutical products
Award outcome
- Awarded value
- £48,571,280
- Award date
- 14 April 2025
- Contract period
- — → 27 June 2027
- Biogen Idec Ltd
- Merck Serono Limited
- Orifarm UK
- Ranbaxy (UK) Ltd
- STADA UK - Thornton & Ross
- Sandoz Ltd
- Teva UK Ltd
- Viatris UK Healthcare Ltd
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract
2 May 2025
View notice ↗Tender Update
8 January 2025
View notice ↗Contract Notice
7 January 2025
View notice ↗
Contracting authority
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
BuyerEdinburgh, United Kingdom
Authority website ↗
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.